• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】14383

【品名】6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine

【CA登记号】19916-73-5

【 分 子 式 】C12H11N5O

【 分 子 量 】241.25244

【元素组成】C 59.74% H 4.6% N 29.03% O 6.63%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(XII)

1) The cyclization of ketene diethylketal (I) with diethyl fumarate (II) in hot tert-butanol gives trans-3,3-diethoxycyclobutane-1,2-dicarboxylic acid diethyl ester (III), which is saponified with KOH in hot methanol to the corresponding racemic diacid (IV). The condensation of (IV) with (R)-(-)-2-phenylglycinol (V) by means of dicyclohexylcarbodiimide (DCC) in dichloromethane followed by fractionated crystallization of the resulting diastereomeric mixture yields the diamide (VI). The hydrolytic reduction of (VI) by sequential treatments with trimethylsilyl chloride and imidazole, dinitrogen tetraoxide and finally with LiBH4 affords (S,S)-trans-3,3-diethoxycyclobutane-1,2-dimethanol (VII), which is benzoylated with benzoyl chloride in pyridine to the dibenzoate (VIII). The cleavage of the ketal group of (VIII) with H2SO4 in acetonitrile gives the cyclobutanone (IX), which is reduced with LS-Selectride in THF yielding [1S-(1alpha,2beta,3beta)]-3-hydroxycyclobutane-1,2-dimethanol 1,2-dibenzoate (X). The reaction of (X) with p-toluenesulfonyl chloride affords the corresponding tosylate (XI), which is condensed with 6-O-benzylguanidine (XII) by means of K2CO3 and 18-crown-6 in hot DMF giving [1R-(1alpha,2beta,3alpha)]-6-O-benzyl-9-[2,3-di(benzoyloxymethyl) cyclobutyl]guanine (XIII). Finally, this compound is treated with sodium methoxide in hot methanol. 2) The reaction of 6-chloropurine-2-amine (XIV) with 47% HI gives 6-iodopurine-2-amine (XV), which is condensed with [1S-(1alpha,2beta,3beta)]-3-(trifluoromethylsulfonyloxy)cyclobutane-1,2-dimethanol 1,2-dibenzoate (XVI) (obtained by treatment of the previously described cyclobutanol [X] with trifluromethanesulfonyl anhydride [Tf2O]) by means of benzyltriethylammonium hydroxide and pyridine in dichloromethane to afford the condensed iodopurine (XVII). The reaction of (XVII) with sodium methoxide hydrolyzes the benzoyl groups affording the 6-O-methylguanine derivative (XVIII), which is finally treated with aqueous HCl at 95 C.

1 Ireland, C.; Leeson, P.A.; Castaner, J.; Lobucavir. Drugs Fut 1997, 22, 4, 359.
2 Bisacchi, G.S.; Singh, J.; Godfrey, J.D. Jr.; Kissick, T.P.; Mitt, T.; Malley, M.F.; Di Marco, J.D.; Gougoutas, J.Z.; Mueller, R.H.; Zahler, R.; Regioselective coupling of tetraalkylammonium salts of 6-iodo-2-aminopurine to a cyclobutyl triflate: Efficient preparation of homochiral BMS-180,194, a potent antiviral carbocyclic nucleoside. J Org Chem 1995, 60, 9, 2902-5.
3 Singh, J.; Bisacchi, G.S.; Godfrey, J.D. Jr.; Mitt, T.; Mueller, R.H.; Zahler, R.; Kissick, T.P. (Bristol-Myers Squibb Co.); Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process. EP 0579421 .
4 Bisacchi, G.S.; Mitt, T. (Bristol-Myers Squibb Co.); Intermediates for an optically active cyclobutane nucleoside. US 5306837 .
5 Bisacchi, G.S.; Braitman, A.; Cianci, C.W.; et al.; Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogues. J Med Chem 1991, 34, 4, 1415-21.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14372 Ethene, 1,1-diethoxy-; 1-ethoxyvinyl ethyl ether; 1,1-diethoxyethylene 2678-54-8 C6H12O2 详情 详情
(II) 14373 diethyl (E)-2-butenedioate; Diethyl Fumarate 1520-50-9 C8H12O4 详情 详情
(III) 14374 diethyl (1S,2R)-3,3-diethoxy-1,2-cyclobutanedicarboxylate C14H24O6 详情 详情
(IV) 14375 (1S,2R)-3,3-diethoxy-1,2-cyclobutanedicarboxylic acid C10H16O6 详情 详情
(V) 14376 (2R)-2-amino-2-phenyl-1-ethanol; (R)-(-)-2-phenylglycinol; (R)-2-amino-2-phenyl-1-ethanol 56613-80-0 C8H11NO 详情 详情
(VI) 14377 (1S,2R)-3,3-diethoxy-N(2)-[(1R)-2-hydroxy-1-phenylethyl]-N(1)-[(1R)-2-methoxy-1-phenylethyl]-1,2-cyclobutanedicarboxamide C27H36N2O6 详情 详情
(VII) 14378 [(1S,4S)-2,2-diethoxy-4-(hydroxymethyl)cyclobutyl]methanol C10H20O4 详情 详情
(VIII) 14379 [(1S,4S)-4-[(benzoyloxy)methyl]-2,2-diethoxycyclobutyl]methyl benzoate C24H28O6 详情 详情
(IX) 14380 [(1S,2S)-2-[(benzoyloxy)methyl]-4-oxocyclobutyl]methyl benzoate C20H18O5 详情 详情
(X) 14381 [(1S,2S,4S)-2-[(benzoyloxy)methyl]-4-hydroxycyclobutyl]methyl benzoate C20H20O5 详情 详情
(XI) 14382 ((1S,2S,3S)-2-[(benzoyloxy)methyl]-3-[[(4-methylphenyl)sulfonyl]oxy]cyclobutyl)methyl benzoate C27H26O7S 详情 详情
(XII) 14383 6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine 19916-73-5 C12H11N5O 详情 详情
(XIII) 14384 [(1S,2R,3R)-3-[2-amino-6-(benzyloxy)-9H-purin-9-yl]-2-[(benzoyloxy)methyl]cyclobutyl]methyl benzoate C32H29N5O5 详情 详情
(XIV) 11644 6-Chloro-9H-purin-2-amine; 6-Chloro-9H-purin-2-ylamine; 2-Amino-6-chloropurine 10310-21-1 C5H4ClN5 详情 详情
(XV) 14386 6-iodo-9H-purin-2-ylamine; 6-iodo-9H-purin-2-amine C5H4IN5 详情 详情
(XVI) 14387 ((1S,2S,4S)-2-[(benzoyloxy)methyl]-4-[[(trifluoromethyl)sulfonyl]oxy]cyclobutyl)methyl benzoate C21H19F3O7S 详情 详情
(XVII) 14388 [(1R,2R,4S)-2-(2-amino-6-iodo-9H-purin-9-yl)-4-[(benzoyloxy)methyl]cyclobutyl]methyl benzoate C25H22IN5O4 详情 详情
(XVIII) 14389 [(1R,2S,4R)-2-(hydroxymethyl)-4-(6-methoxy-9H-purin-9-yl)cyclobutyl]methanol C12H16N4O3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XII)

5) The thermal rearrangement of 3-bromo-4,6-dimethyl-2-oxo-2H-pyran-5-carboxylic acid ethyl ester (XXXIX) with NaOH in refluxing water gives (rac)-trans-3-methylenecyclopropane-1,2-dicarboxylic acid (XL), which was submitted to optical resolution with (R)-alpha-methylbenzylamine (XLI) yielding, after crystallization, the corresponding (R,R)-enantiomeric salt (XLII). The decomposition of the salt and esterification of the free acid with trimethyl orthoformate affords (1R-trans)-3-methylenecyclopropane-1,2-dicarboxylic acid dimethyl ester (XLIII), which is reduced with LiAlH4 in THF to (1R-trans)-3-methylenecyclopropane-1,2-dimethanol (XLIV). The esterification of (XLIV) with benzoic anhydride and triethylamine in ethyl acetate affords the corresponding dibenzoate (XLV), which is epoxidized with m-chloroperbenzoic acid (MCPBA) in dichloromethane to afford the oxirane (XLVI). The isomerization of (XLVI) by means of LiI in ethyl acetate gives (2S-trans)-2,3-bis(benzoyloxymethyl)cyclobutanone (IX), which is reduced with lithium trisiamylborohydride in THF yielding [1S-(1alpha,2beta,3beta)]-3-hydroxycyclobutane-1,2-dimethanol 1,2-dibenzoate ester (X). The reaction of (X) with p-toluenesulfonyl chloride in pyridine affords the corresponding tosylate (XI), which is condensed with 6-O-benzylguanine (XII) by means of K2CO3 and 18-crown-6 in DMF yielding the substituted guanine (XIII). Finally, this compound is deprotected by treatment first with sodium methoxide in hot methanol, and then with 3N HCl.

1 Ireland, C.; Leeson, P.A.; Castaner, J.; Lobucavir. Drugs Fut 1997, 22, 4, 359.
2 Godfrey, J.D. Jr.; Mueller, R.H.; Kissick, T.P.; Singh, J. (Bristol-Myers Squibb Co.); Process and intermediates for the preparation of an antiviral agent containing a cyclobutyl group. EP 0535448 .
3 Godfrey, J.D. Jr.; Mueller, R.H.; Kissick, T.P.; Singh, J. (Bristol-Myers Squibb Co.); Process for the preparation of an antiviral agent. US 5525726 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IX) 14380 [(1S,2S)-2-[(benzoyloxy)methyl]-4-oxocyclobutyl]methyl benzoate C20H18O5 详情 详情
(X) 14381 [(1S,2S,4S)-2-[(benzoyloxy)methyl]-4-hydroxycyclobutyl]methyl benzoate C20H20O5 详情 详情
(XI) 14382 ((1S,2S,3S)-2-[(benzoyloxy)methyl]-3-[[(4-methylphenyl)sulfonyl]oxy]cyclobutyl)methyl benzoate C27H26O7S 详情 详情
(XII) 14383 6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine 19916-73-5 C12H11N5O 详情 详情
(XIII) 63903 [(1R,2R,4S)-2-[2-amino-6-(benzyloxy)-9H-purin-9-yl]-4-(hydroxymethyl)cyclobutyl]methanol C18H21N5O3 详情 详情
(XXXIX) 14410 ethyl 3-bromo-2-hydroxy-4,6-dimethyl-2H-pyran-5-carboxylate C10H13BrO4 详情 详情
(XL) 14411 (1R,2R)-3-methylene-1,2-cyclopropanedicarboxylic acid 499-02-5 C6H6O4 详情 详情
(XLI) 10039 (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine 3886-69-9 C8H11N 详情 详情
(XLII) 14412 (R,R)-3-methylenecyclopropane-1,2-dicarboxylic acid (R)-1-phenylethylamine salt C14H17NO4 详情 详情
(XLIII) 14413 dimethyl (1R,2R)-3-methylene-1,2-cyclopropanedicarboxylate C8H10O4 详情 详情
(XLIV) 14414 [(1R,2R)-2-(hydroxymethyl)-3-methylenecyclopropyl]methanol C6H10O2 详情 详情
(XLV) 14415 [(1R,2R)-2-[(benzoyloxy)methyl]-3-methylenecyclopropyl]methyl benzoate C20H18O4 详情 详情
(XLVI) 14416 [(4S,5S)-5-[(benzoyloxy)methyl]-1-oxaspiro[2.2]pent-4-yl]methyl benzoate C20H18O5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VII)

The regioselective reaction of cyclopentadiene (I) and sodium or commercial sodium cyclopentadienide (II) with benzyl chloromethyl ether (III) by means of the chiral catalyst (-)-diisopinocampheylborane in THF, followed by hydroxylation with H2O2/NaOH, gives (1S-trans)-2-(benzyloxymethyl)-3-cyclopenten-1-ol (IV), which is regioselectively epoxidized with tert-butyl hydroperoxide and vanadyl acetylacetonate in 2,2,4-trimethylpentane, yielding [1S-(1alpha,2alpha,3beta,5alpha)-2-(benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol (V). The protection of (V) with benzyl bromide and NaH affords the corresponding ether (VI), which is condensed with 6-O-benzylguanine (VII) by means of LiH in DMF to give the guanine derivative (VIII). The protection of the amino group of (VIII) with 4-methoxyphenyl(diphenyl)chloromethane (IX), TEA and DMAP in dichloromethane gives intermediate (X), which is oxidized at the free hydroxyl group with methylphosphonic acid, DCC and oxalic acid in DMSO or Dess Martin periodinane in dichloromethane, yielding the cyclopentanone derivative (XI). The reaction of (XI) with (i) Zn/TiCl4/CH2Br2 complex in THF/CH2Cl2, (ii) activated Zn/PbCl2/CH2I2/TiCl4 in THF/CH2Cl2 (2), (iii) Nysted reagent/TiCl4 in THF/CH2Cl2 or (iv) Tebbe reagent in toluene affords the corresponding methylene derivative (XII), which is partially deprotected with 3N HCl in hot THF, providing the dibenzylated compound (XI). Finally, this compound is treated with BCl3 in dichloromethane. (Scheme 18263401a)

1 Bisacchi, G.S.; Chao, S.T.; Bachard, C.; et al.; BMS-200475. A novel carbocyclic 2'-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro. Bioorg Med Chem Lett 1997, 7, 2, 127.
2 Castaner, J.; Graul, A.; BMS-200475. Drugs Fut 1999, 24, 111, 1173.
3 Zahler, R.; Slusarchyk, W.A. (Bristol-Myers Squibb Co.); Hydroxymethyl(methylenecyclopentyl)purines and pyrimidines. EP 0481754; JP 1992282373; US 5206244 .
4 Bisacchi, G.S.; Sundeen, J.E. (Bristol-Myers Squibb Co.); Improved process for preparing the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one. WO 9809964 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11183 1,3-Cyclopentadiene C5H6 详情 详情
(II) 29887 Sodium cyclopentadienide 4984-82-1 C5H5Na 详情 详情
(III) 14560 Benzyl chloromethyl ether; 1-[(chloromethoxy)methyl]benzene 3587-60-8 C8H9ClO 详情 详情
(IV) 29888 (1S,2R)-2-[(benzyloxy)methyl]-3-cyclopenten-1-ol C13H16O2 详情 详情
(V) 29889 (1S,2R,3S,5R)-2-[(benzyloxy)methyl]-6-oxabicyclo[3.1.0]hexan-3-ol C13H16O3 详情 详情
(VI) 29890 (1S,2R,3S,5R)-3-(benzyloxy)-2-[(benzyloxy)methyl]-6-oxabicyclo[3.1.0]hexane; benzyl (1S,2R,3S,5R)-2-[(benzyloxy)methyl]-6-oxabicyclo[3.1.0]hex-3-yl ether C20H22O3 详情 详情
(VII) 14383 6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine 19916-73-5 C12H11N5O 详情 详情
(VIII) 29891 (1S,2S,3S,5S)-5-[2-amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentanol C32H33N5O4 详情 详情
(IX) 12700 4-[Chloro(diphenyl)methyl]phenyl methyl ether; 1-[Chloro(diphenyl)methyl]-4-methoxybenzene; p-Anisylchlorodiphenylmethane 14470-28-1 C20H17ClO 详情 详情
(X) 29892 (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-[[(4-methoxyphenyl)(diphenyl)methyl]amino]-9H-purin-9-yl)-2-[(benzyloxy)methyl]cyclopentanol C52H49N5O5 详情 详情
(XI) 29893 (2R,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-[[(4-methoxyphenyl)(diphenyl)methyl]amino]-9H-purin-9-yl)-2-[(benzyloxy)methyl]cyclopentanone C52H47N5O5 详情 详情
(XII) 29894 6-(benzyloxy)-9-[(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylenecyclopentyl]-N-[(4-methoxyphenyl)(diphenyl)methyl]-9H-purin-2-amine; N-(6-(benzyloxy)-9-[(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylenecyclopentyl]-9H-purin-2-yl)-N-[(4-methoxyphenyl)(diphenyl)methyl]amine 142217-80-9 C53H49N5O4 详情 详情
(XIII) 29895 2-amino-9-[(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one 142217-81-0 C26H27N5O3 详情 详情

合成路线4

该中间体在本合成路线中的序号:(XIII)

The condensation of diethyl malonate (I) with (R)-(-)-epichlorohydrin (II) by means of NaOEt in ethanol gives (3aS,4aR)-3-oxo-3,3a,4,4a-tetrahydro-1H-cyclopropa[c]furan-3a-carboxylic acid ethyl ester (III), which is selectively reduced at the lactone group by means of sodium borohydride in ethanol to yield (1R,2R)-1,2-bis(hydroxymethyl)cyclopropanecarboxylic acid ethyl ester (IV). The protection of (IV) with 2,2-dimethoxypropane (V) and Ts-OH in DMF affords the cyclic acetonide (VI), which is reduced with LiBH4 in THF to provide the hydroxymethyl acetonide (VII). The protection of the OH group of (VII) with benzyl bromide and NaH in DMF gives the benzyl ether (VIII), which is treated with HCl in THF/water to cleave the acetonide ring and yield the bis hydroxymethyl compound (IX). The acylation of (IX) with benzoyl chloride and pyridine affords the dibenzoate (X), which is debenzylated with H2 over Pd/C in ethanol/acetic acid to provide (1S,2R)-1,2-bis(benzoyloxymethyl)cyclopropanemethanol (XI). The reaction of (XI) with Ts-OH and DMAP in dichloromethane gives the corresponding tosylate (XII), which is condensed with 6-O-benzylguanine (XIII) by means of K2CO3 in DMF to yield the fully protected nucleoside (XIV). The hydrolysis of the benzoyl group of (XIV) by means of NaOMe in methanol affords the dihydroxy compound (XV), which is finally debenzylated by means of HCl in ethanol/water to provide the target guanine cyclopropyl nucleoside.

1 Sekiyama, T.; et al.; Synthesis and antiviral activity of novel acyclic nucleosides: Discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses. J Med Chem 1998, 41, 8, 1284.
2 Hatsuya, S.; Sekiyama, T.; Tsuji, T.; Iwayama, S.; Okunishi, M. (Ajinomoto Co., Inc.); Cyclopropane deriv.. EP 0502690; JP 1993194421; US 5342840; US 5449840 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16829 Diethyl malonate 105-53-3 C7H12O4 详情 详情
(II) 38067 (2R)-2-(Chloromethyl)oxirane; (R)-Epichlorohydrin 51594-55-9 C3H5ClO 详情 详情
(III) 38068 ethyl (1S,5R)-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carboxylate C8H10O4 详情 详情
(IV) 38069 ethyl (1R,2R)-1,2-bis(hydroxymethyl)cyclopropanecarboxylate C8H14O4 详情 详情
(V) 10722 1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane 77-76-9 C5H12O2 详情 详情
(VI) 53924 ethyl (1R,7R)-4,4-dimethyl-3,5-dioxabicyclo[5.1.0]octane-1-carboxylate C11H18O4 详情 详情
(VII) 53925 [(7R)-4,4-dimethyl-3,5-dioxabicyclo[5.1.0]oct-1-yl]methanol C9H16O3 详情 详情
(VIII) 53926 benzyl [(7R)-4,4-dimethyl-3,5-dioxabicyclo[5.1.0]oct-1-yl]methyl ether; (1S,7R)-1-[(benzyloxy)methyl]-4,4-dimethyl-3,5-dioxabicyclo[5.1.0]octane C16H22O3 详情 详情
(IX) 53927 [(1R,2R)-2-[(benzyloxy)methyl]-2-(hydroxymethyl)cyclopropyl]methanol C13H18O3 详情 详情
(X) 53928 {(1R,2S)-2-[(benzoyloxy)methyl]-2-[(benzyloxy)methyl]cyclopropyl}methyl benzoate C27H26O5 详情 详情
(XI) 53929 [(1R,2S)-2-[(benzoyloxy)methyl]-2-(hydroxymethyl)cyclopropyl]methyl benzoate C20H20O5 详情 详情
(XII) 53930 [(1R,2R)-2-[(benzoyloxy)methyl]-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)cyclopropyl]methyl benzoate C27H26O7S 详情 详情
(XIII) 14383 6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine 19916-73-5 C12H11N5O 详情 详情
(XIV) 53931 {(1R,2S)-2-{[2-amino-6-(benzyloxy)-9H-purin-9-yl]methyl}-2-[(benzoyloxy)methyl]cyclopropyl}methyl benzoate C32H29N5O5 详情 详情
(XV) 53932 [(1S,2R)-1-{[2-amino-6-(benzyloxy)-9H-purin-9-yl]methyl}-2-(hydroxymethyl)cyclopropyl]methanol n/a C18H21N5O3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XXXVII)

In a further procedure, the prochiral diol (XX) was converted to the asymmetric mono-stearate ester (XXXII) employing vinyl stearate (XXXI) and lipase PS 30. After tosylation of alcohol (XXXII), the resulting diethoxy acetal (XXXIII) was hydrolyzed to aldehyde (XXXIV) employing different acidic catalysts. Reduction of aldehyde (XXXIV) to the corresponding alcohol (XXXV) was effected by means of catalytic hydrogenation over Ra-Ni or borane-tert-butylamine complex. Alcohol (XXXV) was further condensed with N-Cbz-L-valine (XVI), producing the diester tosylate (XXXVI). The analogous N-Boc- and N-Alloc-protected valine esters were similarly prepared. 6-Benzyloxy-2-aminopurine (XXXVII) was prepared by treatment of chloropurine (I) with benzyl alcohol and NaH or NaOH. Alkylation of purine (XXXVII) with tosylate (XXXVI) furnished adduct (XXXVIII), which was finally deprotected by catalytic hydrogenation. Optionally, tosylate (XXXVI) was condensed with chloropurine (I) to give (XXXIX). Hydrolysis of the chloropurine ring of (XXXIX) to the guanine derivative (XIII) employing either Et3N or HOAc, followed by catalytic hydrogenation as above, provided an alternative access to the title compound.

1 Synthesis of acyclic nucleoside derivs.. WO 9834917 .
2 Synthesis of acyclic nucleoside derivs.. WO 0008025 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11644 6-Chloro-9H-purin-2-amine; 6-Chloro-9H-purin-2-ylamine; 2-Amino-6-chloropurine 10310-21-1 C5H4ClN5 详情 详情
(XIII) 52965 (2R)-2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]-4-[((2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanoyl)oxy]butyl stearate C41H64N6O7 详情 详情
(XVI) 18092 (2S)-2-[[(benzyloxy)carbonyl]amino]-3-methylbutyric acid C13H17NO4 详情 详情
(XX) 52969 2-(2,2-Diethoxyethyl)-1,3-propanediol; 2-Hydroxymethyl-4,4-diethoxybutanol 55387-85-4 C9H20O4 详情 详情
(XXXI) 52979 vinyl stearate 111-63-7 C20H38O2 详情 详情
(XXXII) 52980 (2R)-4,4-diethoxy-2-(hydroxymethyl)butyl stearate n/a C27H54O5 详情 详情
(XXXIII) 52981 (2S)-4,4-diethoxy-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)butyl stearate n/a C34H60O7S 详情 详情
(XXXIV) 52982 (2S)-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)-4-oxobutyl stearate n/a C30H50O6S 详情 详情
(XXXV) 52983 (2S)-4-hydroxy-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)butyl stearate n/a C30H52O6S 详情 详情
(XXXVI) 52984 (2S)-4-[((2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanoyl)oxy]-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)butyl stearate n/a C43H67NO9S 详情 详情
(XXXVII) 14383 6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine 19916-73-5 C12H11N5O 详情 详情
(XXXVIII) 52985 (2R)-2-[(2-amino-6-chloro-9H-purin-9-yl)methyl]-4-[((2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanoyl)oxy]butyl stearate n/a C41H63ClN6O6 详情 详情
(XXXIX) 52986 (2R)-2-{[2-amino-6-(benzyloxy)-9H-purin-9-yl]methyl}-4-[((2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanoyl)oxy]butyl stearate n/a C48H70N6O7 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

 

1 Zhang L,Zeng Z,et al.2006.Preparation of entecavir.发明专利申请公开说明书.CN 1861602
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14383 6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine 19916-73-5 C12H11N5O 详情 详情
(II) 66320     C25H32O5 详情 详情
(III) 66321 6-(benzyloxy)-9-((1R,2R,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-(2,2-dimethyl-1,3-dioxolan-4-yl)cyclopentyl)-9H-purin-2-amine   C37H41N5O5 详情 详情
(IV) 66322 ((1S,2S,3R,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentyl)methanol   C33H35N5O4 详情 详情
(V) 66323 6-(benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-9H-purin-2-amine 204845-95-4 C33H33N5O3 详情 详情
Extended Information